Impact Biomedical Inc. (NYSEAMERICAN:IBO) Stock Short Interest Report for September

Impact Biomedical Inc. (NYSEAMERICAN:IBO) was the recipient of a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 30,169 shares, a decline of 94.3% from the September 15th total of 526,986 shares. Approximately 3.2% of the company’s shares are sold short. Based on an average daily trading volume, of 15,208 shares, the days-to-cover ratio is presently 2.0 days.

Impact Biomedical Trading Up 3.4%

Impact Biomedical stock traded up $0.14 during mid-day trading on Friday, hitting $4.25. The company’s stock had a trading volume of 4,014 shares, compared to its average volume of 13,862. Impact Biomedical has a 1 year low of $4.06 and a 1 year high of $10.47. The stock’s fifty day moving average is $5.79 and its two-hundred day moving average is $6.57.

Impact Biomedical (NYSEAMERICAN:IBO) last posted its earnings results on Friday, August 7th. The company reported ($0.13) earnings per share (EPS) for the quarter. The business had revenue of $0.00 million for the quarter. Impact Biomedical had a return on equity of 8.81% and a net margin of 2,254.28%.

About Impact Biomedical

Impact Biomedical, Inc is a biotechnology and life sciences company focused on developing and commercializing biomedical technologies, pharmaceutical products and related health solutions. Its activities have included research into antiviral, antimicrobial and anti-inflammatory applications, with an emphasis on technologies intended to address infectious diseases and other public health needs.

The company has described a portfolio of biomedical intellectual property and development programs rather than a broad portfolio of established commercial products.